RA Capital Management, L.P.

Company	Share, %
Vor Biopharma Inc.	51.92
Eliem Therapeutics, Inc.	47.44
Aerovate Therapeutics, Inc.	29.66
PepGen Inc.	29.03
Acrivon Therapeutics, Inc.	26.43
Acumen Pharmaceuticals, Inc.	24.65
Tyra Biosciences, Inc.	22.65
Janux Therapeutics, Inc.	18.39
Ascendis Pharma A/S	16.59
DICE Therapeutics, Inc.	16.46
Nkarta, Inc.	15.21
Werewolf Therapeutics, Inc.	13.76
GH Research PLC	12.38
iTeos Therapeutics, Inc.	12.35
Icosavax, Inc.	11.91
ARS Pharmaceuticals, Inc.	10.99
Cidara Therapeutics, Inc.	10.7
BELLUS Health Inc.	9.97
Geron Corporation	9.96
Adicet Bio, Inc.	9.9